Femasys is a commercial-stage medtech company targeting OB/GYNs with in-office fertility and permanent birth control ...
A federal judge cited the company’s investigation of video recordings in which the worker immediately left the worksite after ...
After nearly three decades without a new way to fight the virus, one group of patients finally has another option.
Morning Overview on MSN
An injection cut visceral fat 12.01% in a trial where the placebo group gained it
Caliway Biopharmaceuticals reported that its experimental fat-cell injection, CBL-514, reduced visceral fat volume by an ...
A new systematic review of 15 studies confirms semaglutide's clinically meaningful weight-loss benefits while cautioning that ...
A new mathematical study uses degree-based topological indices, Shannon entropy and adjacency eigenvalues to predict the ...
Jonathan, an estimated 194-year-old giant tortoise, retains unusually orderly DNA regulation in pathways linked to cellular maintenance. Genome and epigenome comparisons offer clues to extreme ...
As the availability of post-market real-world evidence expands, more attention to its promise, limitations, and oversight in ...
The US Food and Drug Administration (FDA) approved Hovilpri (pritelivir) tablets for adults with weakened immune systems (i.e ...
BRIUMVI was associated with a lower risk of 24-week confirmed disability progression (CDP24) compared with both ocrelizumab and ofatumumab, with a 44% lower relative hazard versus ocrelizumab (HR ...
The question surrounding GLP-1RAs is not simply whether they can change the brain, but whether that is enough to change the ...
Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results